| Ross Samuel Oliver Jr, MD | |
|
2335 Chesterfield Avenue,, Suite 101, Charleston, WV 25304-1066 | |
| (304) 344-3785 | |
| (304) 344-3765 |
| Full Name | Ross Samuel Oliver Jr |
|---|---|
| Gender | Male |
| Speciality | Urology |
| Experience | 41 Years |
| Location | 2335 Chesterfield Avenue,, Charleston, West Virginia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053497453 | NPI | - | NPPES |
| 0216253040000 | Other | WV | TRICARE |
| 185112 | Other | WV | SELECT NET |
| 340002703 | Other | WV | RAILROAD MC |
| 001721031 | Other | WV | BC BS |
| 4242731 | Other | WV | AETNA |
| 0130039000 | Medicaid | WV | |
| 1393063 | Other | WV | MC UMW |
| 1508836 | Other | WV | CIGNA |
| 1002718509 | Other | WV | ACORDIA PEIA |
| 221960 | Other | WV | CARELINK |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208800000X | Urology | 13925 (West Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Charleston Area Medical Center | Charleston, WV | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Charleston Area Medical Center Inc | 3375441637 | 675 |
News Archive
Geron Corporation announced today that the U.S. Food and Drug Administration (FDA) has notified the company that the clinical hold placed on Geron's Investigational New Drug (IND) application has been lifted and the company's Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury may proceed.
Pluristem Therapeutics Inc. (PSTI), a leading developer of placenta-based cell therapy products, has announced that the Japan Patent Office has granted the Company two key patents addressing...
The National Academy of Sports Medicine (NASM), a global leader in sports performance training and personal training certification, today announced the release of an enhanced version if its Performance Enhancement Specialist (NASM PES) course, the "NASM Essentials of Sports Performance Training."
Nursing homes and long-term care facilities, where 182,000 Americans perished during the covid pandemic, have taken heat from government regulators, residents and their families. Now the industry is hearing it from an unexpected source: their investors.
› Verified 2 days ago
| Entity Name | Charleston Area Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124248752 PECOS PAC ID: 3375441637 Enrollment ID: O20031223000426 |
News Archive
Geron Corporation announced today that the U.S. Food and Drug Administration (FDA) has notified the company that the clinical hold placed on Geron's Investigational New Drug (IND) application has been lifted and the company's Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury may proceed.
Pluristem Therapeutics Inc. (PSTI), a leading developer of placenta-based cell therapy products, has announced that the Japan Patent Office has granted the Company two key patents addressing...
The National Academy of Sports Medicine (NASM), a global leader in sports performance training and personal training certification, today announced the release of an enhanced version if its Performance Enhancement Specialist (NASM PES) course, the "NASM Essentials of Sports Performance Training."
Nursing homes and long-term care facilities, where 182,000 Americans perished during the covid pandemic, have taken heat from government regulators, residents and their families. Now the industry is hearing it from an unexpected source: their investors.
› Verified 2 days ago
| Entity Name | Montgomery General Hospital, Inc |
|---|---|
| Entity Type | Part A Provider - Critical Access Hospital |
| Entity Identifiers | NPI Number: 1619913647 PECOS PAC ID: 6204735269 Enrollment ID: O20050110000040 |
News Archive
Geron Corporation announced today that the U.S. Food and Drug Administration (FDA) has notified the company that the clinical hold placed on Geron's Investigational New Drug (IND) application has been lifted and the company's Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury may proceed.
Pluristem Therapeutics Inc. (PSTI), a leading developer of placenta-based cell therapy products, has announced that the Japan Patent Office has granted the Company two key patents addressing...
The National Academy of Sports Medicine (NASM), a global leader in sports performance training and personal training certification, today announced the release of an enhanced version if its Performance Enhancement Specialist (NASM PES) course, the "NASM Essentials of Sports Performance Training."
Nursing homes and long-term care facilities, where 182,000 Americans perished during the covid pandemic, have taken heat from government regulators, residents and their families. Now the industry is hearing it from an unexpected source: their investors.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ross Samuel Oliver Jr, MD 2335 Chesterfield Avenue,, Suite 101, Charleston, WV 25304-1066 Ph: (304) 344-3785 | Ross Samuel Oliver Jr, MD 2335 Chesterfield Avenue,, Suite 101, Charleston, WV 25304-1066 Ph: (304) 344-3785 |
News Archive
Geron Corporation announced today that the U.S. Food and Drug Administration (FDA) has notified the company that the clinical hold placed on Geron's Investigational New Drug (IND) application has been lifted and the company's Phase I clinical trial of GRNOPC1 in patients with acute spinal cord injury may proceed.
Pluristem Therapeutics Inc. (PSTI), a leading developer of placenta-based cell therapy products, has announced that the Japan Patent Office has granted the Company two key patents addressing...
The National Academy of Sports Medicine (NASM), a global leader in sports performance training and personal training certification, today announced the release of an enhanced version if its Performance Enhancement Specialist (NASM PES) course, the "NASM Essentials of Sports Performance Training."
Nursing homes and long-term care facilities, where 182,000 Americans perished during the covid pandemic, have taken heat from government regulators, residents and their families. Now the industry is hearing it from an unexpected source: their investors.
› Verified 2 days ago
Rodney D. Dean, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 66 Quarry Ridge, Charleston, WV 25304 Phone: 304-330-4865 | |
James P. Tierney, DO Urology Medicare: Accepting Medicare Assignments Practice Location: 11 Courtney Drive, Charleston, WV 25304 Phone: 304-925-8521 Fax: 304-925-8523 | |
Bashir R. Sankari, M.D. Urology Medicare: Medicare Enrolled Practice Location: 501 Morris Street, 5 West, Camc Renal Transplant Center, Charleston, WV 25301 Phone: 304-388-7823 Fax: 304-388-7820 | |
Shozo Kurusu, MD Urology Medicare: Not Enrolled in Medicare Practice Location: 1313 Quarrier St, Charleston, WV 25301 Phone: 304-792-6275 | |
Samuel Gray Deem, DO Urology Medicare: Accepting Medicare Assignments Practice Location: 3100 Maccorkle Ave Se, Suite 602, Charleston, WV 25304 Phone: 304-388-5120 Fax: 304-388-5125 | |
Dr. Hugh Anthony Smith, M.D. Urology Medicare: Not Enrolled in Medicare Practice Location: 470 Silver Maple Rdg Apt 10, Charleston, WV 25306 Phone: 304-388-5432 |